Literature DB >> 10616972

New telemetric system for daily pulmonary function surveillance of lung transplant recipients.

F M Wagner1, A Weber, J W Park, S Schiemanck, S M Tugtekin, V Gulielmos, S Schüler.   

Abstract

BACKGROUND: Following lung transplantation, prompt diagnosis and therapy of acute pulmonary rejection and infection episodes relies primarily upon changes in pulmonary function and determines long-term outcome. We tested a new system that allows daily monitoring of the patient's pulmonary status even after discharge from the hospital.
METHODS: Seven lung transplant recipients from our center were equipped with a telemetric monitoring device consisting of a portable flowmeter and a special modem unit. The flowmeter measures forced vital capacity (FVC), forced expiratory volume per second (FEV1), and mid expiratory flows (MEFs), encodes information like fever, cough, and dyspnea in a binary code form, and stores all values in a 32 kB memory unit. After its use, the patient positions the flowmeter onto the modem unit which automatically connects to a central computer at our center to transfer all saved data. The whole set can be used via any regular phone jack. The patient's file in the computer can be checked every day.
RESULTS: All patients learned to use the unit during their postoperative stay or during later follow-up, and were able to apply the system at home. In a mean follow-up period of 10.3+/-2.2 months, 15 episodes of significant deterioration in home pulmonary function tests (PFTs) (>10%) were registered in 6 patients, which were all confirmed by in-hospital body plethysmography. They resulted in diagnoses of 4 episodes of acute rejection, 6 cases of beginning bacterial pneumonia, and 5 cases of, most likely, viral tracheobronchitis. Only 1 patient had to be admitted to the hospital. All patients PFTs returned to previous values after treatment.
CONCLUSIONS: Telemetric monitoring of graft function in lung transplant recipients allows reliable early diagnosis and treatment of infection or rejection, which might help to prevent exacerbation of the pathology and reduce quantity of amounting graft dysfunction.

Entities:  

Mesh:

Year:  1999        PMID: 10616972     DOI: 10.1016/s0003-4975(99)01140-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Adherence to home-monitoring and its impact on survival in post-lung transplantation patients.

Authors:  Hojung J Yoon; Hojung Joseph Yoon; Hongfei Guo; Marshall Hertz; Marshall I Hertz; Stanley Finkelstein; Stanley M Finkelstein
Journal:  AMIA Annu Symp Proc       Date:  2008-11-06

2.  Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.

Authors:  N Lechtzin; N West; S Allgood; E Wilhelm; U Khan; N Mayer-Hamblett; M L Aitken; B W Ramsey; M P Boyle; P J Mogayzel; C H Goss
Journal:  Contemp Clin Trials       Date:  2013-09-19       Impact factor: 2.226

Review 3.  Systematic review of home telemonitoring for chronic diseases: the evidence base.

Authors:  Guy Paré; Mirou Jaana; Claude Sicotte
Journal:  J Am Med Inform Assoc       Date:  2007-02-28       Impact factor: 4.497

4.  Using mobile health technology to deliver decision support for self-monitoring after lung transplantation.

Authors:  Yun Jiang; Susan M Sereika; Annette DeVito Dabbs; Steven M Handler; Elizabeth A Schlenk
Journal:  Int J Med Inform       Date:  2016-07-19       Impact factor: 4.046

5.  Automatic event detection in lung transplant recipients based on home monitoring of spirometry and symptoms.

Authors:  Wayne Wang; Stanley M Finkelstein; Marshall I Hertz
Journal:  Telemed J E Health       Date:  2013-07-20       Impact factor: 3.536

6.  A randomized controlled trial comparing health and quality of life of lung transplant recipients following nurse and computer-based triage utilizing home spirometry monitoring.

Authors:  Stanley M Finkelstein; Bruce R Lindgren; William Robiner; Ruth Lindquist; Marshall Hertz; Bradley P Carlin; Arin VanWormer
Journal:  Telemed J E Health       Date:  2013-10-01       Impact factor: 3.536

7.  Time-motion analysis of research nurse activities in a lung transplant home monitoring study.

Authors:  Ruth Lindquist; Arin VanWormer; Bruce Lindgren; Kathleen MacMahon; William Robiner; Stanley Finkelstein
Journal:  Prog Transplant       Date:  2011-09       Impact factor: 1.065

8.  Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction.

Authors:  Chadi A Hage; Julia Klesney-Tait; Keith Wille; Selim Arcasoy; Gordon Yung; Marshall Hertz; Kevin M Chan; Matt Morrell; Hilary Goldberg; Suresh Vedantham; Mary Clare Derfler; Paul Commean; Keith Berman; Ed Spitznagel; Jeff Atkinson; George Despotis
Journal:  Transfus Med       Date:  2021-05-05       Impact factor: 2.019

9.  A comparison of clinic and home spirometry as longtudinal outcomes in cystic fibrosis.

Authors:  Alex Paynter; Umer Khan; Sonya L Heltshe; Christopher H Goss; Noah Lechtzin; Nicole Mayer Hamblett
Journal:  J Cyst Fibros       Date:  2021-08-31       Impact factor: 5.482

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.